ARCHIVES

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Channels More Money To CIS, 17 Offices Funded

March 9, 1990

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

September 28, 2012

NIH offers student loan repayment program, deadline is Dec. 31.

November 21, 2003

Appropriations: Senate Committee Approves 4.5 Percent Cut To Defense Dept. Cancer Research Funding

July 25, 2014

NCI Communications Director Sieber To Retire; Science Planner Waldrop Also To Leave NCI.

September 14, 2001

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010